Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A vial accumulator for use in a high volume pharmacy facility includes: a feed plate having an aperture; a vial staging unit mounted to the feed plate, the vial staging unit comprising at least one receiving compartment; a gate movably mounted to the feed plate, the gate movable relative to the feed plate between a blocking position, wherein the gate prevents a vial from exiting one of the receiving compartments, and a dispensing position, in which the gate allows passage of a vial in one of the receiving compartments through the aperture in the feed plate; and a controller operatively associated with the vial staging unit and the gate.

Abstract: A building module for use in construction of a structure incorporating a plurality of said modules which together form at least part of the structure. Each building module comprises a first peripheral frame of a first size defining a space which receives a layer of barrier material, a second peripheral frame of a second size defining a space which receives a layer of barrier material and which is joined at a first junction to the first peripheral frame of the first size in abutting end to end relationship to form a first auxiliary module. A third peripheral frame has the same size as the first peripheral frame and which defines a space which receives a layer of barrier material. A fourth peripheral frame has the same size as the second peripheral frame and which defines a space which receives a layer of barrier material and which is joined at a second junction to the third peripheral frame of the first size in abutting end to end relationship to form a second auxiliary module.

Abstract: A building module for use in construction of a structure incorporating a plurality of said modules which together form at least part of the structure. Each building module comprises a first peripheral frame of a first size defining a space which receives a layer of barrier material, a second peripheral frame of a second size defining a space which receives a layer of barrier material and which is joined at a first junction to the first peripheral frame of the first size in abutting end to end relationship to form a first auxiliary module. A third peripheral frame has the same size as the first peripheral frame and which defines a space which receives a layer of barrier material. A fourth peripheral frame has the same size as the second peripheral frame and which defines a space which receives a layer of barrier material and which is joined at a second junction to the third peripheral frame of the first size in abutting end to end relationship to form a second auxiliary module.

Abstract: A stair assembly comprising at least two stair modules with each connected to an adjacent module; the stair assembly comprising a first module having first and second side abutments and spanning therebetween a stair tread. There is at least one other abutment surface associated with said first and second side abutments and which provides a bearing surface to receive and retain an adjacent stair module. The second module includes a stair tread which when disposed adjacent the first module is disposed in an us elevated position relative to the stair tread of the first module, wherein the first and second stair module are interconnected via an auxiliary module.

Abstract: A building module for use in construction of a structure incorporating a plurality of said modules which together form at least part of the structure. Each building module comprises a first peripheral frame of a first size defining a space which receives a layer of barrier material, a second peripheral frame of a second size defining a space which receives a layer of barrier material and which is joined at a first junction to the first peripheral frame of the first size in abutting end to end relationship to form a first auxiliary module. A third peripheral frame has the same size as the first peripheral frame and which defines a space which receives a layer of barrier material. A fourth peripheral frame has the same size as the second peripheral frame and which defines a space which receives a layer of barrier material and which is joined at a second junction to the third peripheral frame of the first size in abutting end to end relationship to form a second auxiliary module.

Abstract: A stair assembly comprising at least two stair modules with each connected to an adjacent module; the stair assembly comprising a first module having first and second side abutments and spanning therebetween a stair tread. There is at least one other abutment surface associated with said first and second side abutments and which provides a bearing surface to receive and retain an adjacent stair module. The second module includes a stair tread which when disposed adjacent the first module is disposed in an us elevated position relative to the stair tread of the first module, wherein the first and second stair module are interconnected via an auxiliary module.

Abstract: Fipronil co-formulations are provided herein. The formulations comprise an organic solvent, an alcohol co-solvent, and one or more antioxidants. The formulations provided herein are antiparasitic, and can be used, for example, to combat dog and cat parasites, such as, fleas and ticks.

Abstract: Fipronil formulations and fipronil/S-methoprene co-formulations are provided herein. These formulations optionally contain one or more additional active ingredient(s). The formulations comprise an organic solvent, an alcohol co-solvent, and one or more antioxidants and without any crystallization inhibitor. The formulations provided herein are antiparasitic, and can be used, for example, to combat dog and cat parasites, such as, fleas and ticks.

Abstract: A method and system for facilitating command of a group determines a present rank protocol associated with users of an ad hoc wireless communication network. The method includes identifying at a first wireless device a second wireless device in operative communication with the first wireless device (step 805). A physical parameter measured at the first wireless device is then compared with a physical parameter measured at the second wireless device and wirelessly received at the first wireless device (step 810). A base rank of a user of the first wireless device is then compared with a base rank of a user of the second wireless device (step 815). A present rank of the user of the first wireless device is then determined relative to a present rank of the user of the second wireless device based on comparisons of the physical parameters and the base ranks (step 820).

Abstract: Compounds of formula (I), wherein G1 is CH or N; G2 is CH or N; R1 is a variety of optional substituents; L1 is (1-4C)alkylene; T1 is CH or N; R2 and R3 are independently hydrogen or (1-4C)alkyl or are joined to form a ring; X1 and X2 represent various linking groups; Ar is phenylene or certain heteroaryl rings and Q represents a variety of aromatic or heterocyclic rings systems, and pharmaceutically acceptable salts thereof are described as useful antithrombotic and anticoagulant agents, and are selective Factor Xa inhibitors. Processes for their preparation and pharmaceutical compositions containing them are also described.

Abstract: A radio frequency communications system (100) includes wireless terminals (102) and base sites (104). The wireless terminals communicate with the base sites over a radio frequency channel (106). The base sites are interconnected to each other and other network elements via a packet network. The communication system has a radio frequency channel (400) with time slots (406, 408) for transmission of both delay-sensitive data, such as streaming audio and video, and non-delay-sensitive data. A method and apparatus are provided for determining whether a time slot in the radio frequency channel is to be allocated to delay-sensitive data or non-delay-sensitive data (704, 706, 708). Each packet of data transmitted over the wireless channel has a type of service field (900). The type of service field has a precedence or priority value (902) and a service type (904).

Abstract: Method and apparatus are provided for removing contaminants from a hydrogen processor feed stream, as in a fuel cell power plant (110). Inlet oxidant (38), typically air, required by a catalytic hydrogen processor (34) in a fuel processor (14) for a fuel cell stack assembly (12) in the power plant (110), may contain contaminants such as SO2 and the like. A cleansing arrangement, which includes an accumulator/degasifier (142, 46) acting as a scrubber, and possibly also a water transfer device (118), receives the inlet oxidant and provides the desired cleansing of contaminants. Water in the water transfer device and in the accumulator/degasifier serves to dissolve the water-soluble contaminants and cleanse them from the oxidant stream. The cleansed oxidant stream (138?) is then delivered to the hydrogen processor and to the fuel cell assembly, with minimal inclusion of detrimental contaminants such as sulfur.

Abstract: A fuel processing system (FPS) (120, 220, 320) provides a hydrogen-rich reformate having a reduced level of CO (34, 234, 62), as for use in a fuel cell power plant (120). The FPS includes, in combination, a reformer (30, 230) for converting hydrocarbon feedstock (22) to reformate and a multistage hybrid WGS reactor (150, 250, 350) for converting CO with H2O in the reformate to H2 and CO2 to reduce the CO in the reformate. The multistage hybrid WGS reactor (150, 250, 350) has one stage (154, 254, 352) of active noble metal catalyst (174, 274, 374), typically platinum and/or rhenium, and an other stage (152, 252, 354) of Cu-based WGS catalyst (172, 272, 372), e.g. Cu/ZnO, whereby the collective volume of the one and the other stages is relatively small, being less than about ½ that of prior WGS reactors. The Cu-based WGS catalyst may be modified to reduce self-heat. Protection from sulfur in the reformate is also provided. The multistage hybrid WGS reactor (150, 250, 350) may further include an O2 guard.

Abstract: The invention relates to heterocyclic derivatives of formula (I) A—B—X1—T1(R2)—L1—T2(R3)—X2—Q??(I) or pharmaceutically-acceptable salts thereof, which possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the heterocyclic derivatives, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect.